Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Calvo

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
ESC Heart Failure|December 29, 2021
Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fractionRaquel López-Vilella, Silvia Lozano-Edo, Patricia Arenas Martín, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Combination of granulocyte-monocyte apheresis and ustekinumab: Multicentre and retrospective studyIago Rodríguez-Lago, Claudia Herrera-deGuise, Maia Boscá-Watts, et al.
Clinical Transplantation|December 1, 2021
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better studyConstantino Fernandez Rivera, María Calvo Rodríguez, José Luís Poveda, et al.
Journal of Clinical Medicine|January 8, 2025
Efficacy of the Once-Daily Tacrolimus Formulation LCPT Compared to the Immediate-Release Formulation in Preventing Early Post-Transplant Diabetes in High-Risk Kidney Transplant Patients: A Randomized, Controlled, Open-Label Pilot Study (EUDRACT: 2017-000718-52)Armando Torres, Concepción Rodríguez-Adanero, Constantino Fernández-Rivera, et al.
European Journal of Gastroenterology & Hepatology|September 26, 2024
Adherence to patient blood management strategy in patients with gastrointestinal bleeding: a prospective nationwide multicenter studyJavier Tejedor-Tejada, María Pilar Ballester, Francisco Jose Del Castillo-Corzo, et al.
Hemasphere|September 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphomaNúria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Journal of Clinical Medicine|January 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced ColitisDiego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, et al.
Journal of Clinical Medicine|July 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNPCristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, et al.
Journal of Clinical Medicine|December 23, 2022
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
ESC Heart Failure|December 29, 2021
Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fractionRaquel López-Vilella, Silvia Lozano-Edo, Patricia Arenas Martín, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Combination of granulocyte-monocyte apheresis and ustekinumab: Multicentre and retrospective studyIago Rodríguez-Lago, Claudia Herrera-deGuise, Maia Boscá-Watts, et al.
Clinical Transplantation|December 1, 2021
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better studyConstantino Fernandez Rivera, María Calvo Rodríguez, José Luís Poveda, et al.
Journal of Clinical Medicine|January 8, 2025
Efficacy of the Once-Daily Tacrolimus Formulation LCPT Compared to the Immediate-Release Formulation in Preventing Early Post-Transplant Diabetes in High-Risk Kidney Transplant Patients: A Randomized, Controlled, Open-Label Pilot Study (EUDRACT: 2017-000718-52)Armando Torres, Concepción Rodríguez-Adanero, Constantino Fernández-Rivera, et al.
European Journal of Gastroenterology & Hepatology|September 26, 2024
Adherence to patient blood management strategy in patients with gastrointestinal bleeding: a prospective nationwide multicenter studyJavier Tejedor-Tejada, María Pilar Ballester, Francisco Jose Del Castillo-Corzo, et al.
Hemasphere|September 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphomaNúria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Journal of Clinical Medicine|January 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced ColitisDiego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, et al.
Journal of Clinical Medicine|July 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNPCristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, et al.
Journal of Clinical Medicine|December 23, 2022
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, et al.
Pageof 11